Remove Books Remove Organic Chemistry Remove Therapies
article thumbnail

Welcome to new Director David Hulcoop

The Open Targets Blog

After completing my PhD in organic chemistry at the University of Cambridge, I went to Canada as a Leverhulme Trust postdoctoral fellow. Photo credit: Jeff Dowling, EMBL-EBI What is your professional background? I’m a chemist by training. What are some of the challenges of your new role?

article thumbnail

Marquis Who’s Who Honors David R. Elmaleh, PhD, with Inclusion in Who’s Who in the World

The Pharma Data

A graduate of the Hebrew University of Jerusalem, he earned a Bachelor of Science in chemistry and physics and a Master of Science in physical organic chemistry before completing a Doctor of Philosophy in 1971. Dr. Elmaleh has contributed to more than 130 book chapters, scientific papers, and professional journal articles.

article thumbnail

Empowering women in STEM: Navigating CMC regulatory affairs

Drug Target Review

As Executive Director of CMC Regulatory Affairs at Biohaven , she leads efforts to develop innovative therapies from the clinic to market approval. Throughout her career, Bakrania has held pivotal roles at renowned companies, including Biohaven, where she contributed to the development of therapies, such as migraine treatment Nurtec ODT.

Science 59